You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paliperidone Palmitate

Showing 1 - 25 of 239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Rwanda (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq., Paliperidone Palmitate 75 mg eq.)

Recruiting
  • Schizophrenia
  • Risperidone 3 mg
  • +8 more
  • Butare, Rwanda
  • +4 more
Jan 3, 2023

Schizophrenia (Recent-onset) Trial in Los Angeles (paliperidone palmitate, risperidone)

Completed
  • Schizophrenia (Recent-onset)
  • Los Angeles, California
    UCLA Semel Institute for Neuroscience and Human Behavior
Apr 7, 2022

Paliperidone Palmitate on Clinical Outcomes and Hospital

Completed
  • Schizophrenia
  • Oral Antipsychotics (OAPs)
  • Paliperidone Palmitate 1-Month Formulation (PP1M)
  • Porto, Portugal, Portugal
    Neurobios , Instituto De Neurociências
Jul 12, 2021

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Schizophrenics Trial (Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega], Paliperidone Palmitate 546 MG Intramuscular

Completed
  • Schizophrenics
  • Paliperidone Palmitate 156 MG/ML Prefilled Syringe [Invega]
  • Paliperidone Palmitate 546 MG Intramuscular Suspension, Extended Release [INVEGA TRINZA]
  • (no location specified)
Feb 12, 2021

Schizophrenia Trial in Kigali, Musanze District, Ngoma District (Risperidone 3 mg, Paliperidone Palmitate 50 mg eq.,

Completed
  • Schizophrenia
  • Risperidone 3 mg
  • +8 more
  • Kigali, Rwanda
  • +2 more
Nov 13, 2020

Breakthrough Symptoms With Long-Acting Injectable Medications

Not yet recruiting
  • Schizophrenia
  • Schizophrenia Relapse
  • Second Generation Long-Acting Injectable Antipsychotic Medications
  • (no location specified)
Jul 22, 2022

Tolerability of Paliperidone Palmitate in Korean Schizophrenic

Completed
  • Schizophrenia
  • No intervention
  • KyungKi, Korea, Republic of
    (unnamed)
Feb 1, 2021

Schizophrenia Trial in Worldwide (PP6M injection Dose 1, PP6M injection Dose 2)

Completed
  • Schizophrenia
  • PP6M injection Dose 1
  • PP6M injection Dose 2
  • Ciudad Autónoma De Buenos Aires, Argentina
  • +29 more
Jul 14, 2022

Schizophrenia Trial in United States (Aripiprazole Lauroxil, Paliperidone Palmitate)

Completed
Has Results
  • Schizophrenia
  • Aripiprazole Lauroxil
  • Paliperidone Palmitate
  • Little Rock, Arkansas
  • +15 more
Jul 29, 2020

Schizophrenia Patients Trial in Berlin (Paliperidone Palmitate)

Completed
  • Schizophrenia Patients
  • Paliperidone Palmitate
  • Berlin, New Jersey
    Hassman Research Institute
Nov 5, 2020

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)

Active, not recruiting
  • Schizophrenia
  • +11 more
  • LY03010; paliperidone palmitate
  • INVEGA SUSTENNA
  • Garden Grove, California
  • +8 more
Nov 19, 2021

Long-acting Antipsychotics on Schizophrenia Violence Risk

Unknown status
  • Schizophrenia
  • Paliperidone Palmitate
  • Wuhan, Hubei, China
    Wuhan mental health center
Feb 19, 2020

Schizophrenia Trial in Worldwide (PP6M, PP3M 350 mg eq., PP3M 525 mg eq.)

Completed
Has Results
  • Schizophrenia
  • Rogers, Arkansas
  • +137 more
Nov 11, 2021

Schizophrenia Trial in Worldwide (Paliperidone palmitate 3 month formulation (PP3M))

Completed
  • Schizophrenia
  • Paliperidone palmitate 3 month formulation (PP3M)
  • Rijeka, Croatia
  • +45 more
Apr 17, 2019

Psychotic Disorders, Schizophrenia, Schizoaffective Disorder Trial in Cleveland (CAE-L)

Completed
Has Results
  • Psychotic Disorders
  • +4 more
  • CAE-L
  • Cleveland, Ohio
    University Hospitals Case Medical Center
Dec 6, 2019

Schizophrenia Trial in Catonsville (Paliperidone)

Withdrawn
  • Schizophrenia
  • Catonsville, Maryland
    Maryland Psychiatric Research Center
Mar 1, 2022

Long-acting Antipsychotics for Mental Ill-Health in Pregnancy

Not yet recruiting
  • Schizophrenia
  • +7 more
    • Makurdi, Benue State, Nigeria
    • +5 more
    Mar 9, 2023

    Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders, Stimulant Dependence

    Recruiting
    • Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis)
    • +4 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Aug 17, 2021

    Assessment of Schizophrenia Patients' Clinical Study Experiences

    Not yet recruiting
    • Schizophrenia
      • San Francisco, California
        Power Life Sciences
      Jul 7, 2023

      Schizophrenia Trial in Worldwide (Aripiprazole, Aripiprazole depot, Paliperidone)

      Completed
      • Schizophrenia
      • Innsbruck, Anichstrasse 35, Austria
      • +48 more
      Aug 31, 2020

      Treatment-resistant Schizophrenia Trial in Columbus (Clozapine, Antipsychotics,Other (non-Clozapine))

      Not yet recruiting
      • Treatment-resistant Schizophrenia
      • Columbus, Ohio
        Ohio State University Harding Hospital
      Feb 22, 2023

      Schizophrenia Trial (Fecal microbiota transplantation(FMT), Placebo)

      Not yet recruiting
      • Schizophrenia
      • Fecal microbiota transplantation(FMT)
      • Placebo
      • (no location specified)
      May 6, 2023

      Family Intervention in Recent Onset Schizophrenia Treatment

      Completed
      • Schizophrenia
      • Caregiver psycho-education and skills training
      • +22 more
      • Bullhead City, Arizona
      • +33 more
      Jan 21, 2019

      Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

      Completed
      • Schizophrenia
      • +4 more
      • Abilify maintena
      • Chungju, Chungcheongbuk-do, Korea, Republic of
      • +26 more
      Dec 16, 2021